Page last updated: 2024-10-22

amifostine anhydrous and Di Guglielmo Disease

amifostine anhydrous has been researched along with Di Guglielmo Disease in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Preisler, HD1
Li, B1
Yang, BL1
Huang, RW1
Devemy, E1
Venugopal, P1
Tao, M1
Chopra, H1
Gregory, SA1
Adler, S1
Sivaraman, S1
Toofanfard, P1
Jajeh, A1
Galvez, A1
Robin, E1

Trials

1 trial available for amifostine anhydrous and Di Guglielmo Disease

ArticleYear
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amifostine; Bone Marrow Cells; Cytokines; Female; fms-Like Tyrosine

2000